PET/CT: First-line Restaging Modality in Patients With Suspected Metastatic Breast Cancer Recurrence
A Dirisamer, B.S. Halpern, D Flöry, F Wolf, M Beheshti, M.E. Mayerhoefer and W Langsteger | 01.02.2010
The study performs diagnostic enhanced CT and 18F FDG PET in one investigation, proving modality sensitivity and determining its diagnostic value in restaging breast cancer recurrence. This shows PET/CT can improve staging and alter therapeutic options.